# KM07 Preference Label 2 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_247_Merrow - Task 2e5v8bf2, batch 20260612_011248).
Current status: DRAFT for platform entry.

Studio-selected pair:
- Transcript A = 0.550, 45 steps, 18m 28s.
- Transcript B = 0.400, 32 steps, 15m 34s.
- Bundle IDs not shown in the pasted transcript; record from the download icons on submit.

Evidence read: the pasted PL transcript `9557a9a8-ffdd-47dc-9dbf-ed3eef92d089/pasted-text.txt`, including both final output summaries. This pair appears to reuse the same B trajectory as PL1. That is acceptable as a distinct pair only if the platform accepts it; the new comparison subject is A 0.550 against the same lower-quality B 0.400. Both trajectories saw the duplicate `/docs/.apps_data/calendar` draft copy, and both reported the duplicate draft was identical to the intended `/docs/filesystem` copy.

KEY FINDING: A is better. A identifies alendronate as omitted from the draft list and notes it was not administered inpatient. That is not a complete golden answer, because the visible summary does not show A explicitly leaving the bone-health resumption decision open for nephrology. Still, A avoids the dangerous closure. B explicitly writes that alendronate was "not given inpatient" but "continues on its Sunday schedule," converting an unresolved reconciliation item into a current/resumed medication. That is the central clinical documentation error. A is meaningfully better, but not much better, because A looks like a partial catch rather than a fully correct nephrology-routing answer.

VERDICT: A2 (A better). Button = A+ (one plus sign).

## Justification

Preferred output: A

Transcript A is preferred because it handles the central bone-health item more safely. A says alendronate was omitted from the draft's list and was not administered inpatient. That reflects the key chart fact the model needed to find from the MAR. Transcript B reads the same chart fact in the unsafe direction, saying alendronate was not given inpatient but nevertheless "continues on its Sunday schedule." That closes an unresolved medication-reconciliation issue as if continuation had been established.

Justification: The task rewards a referral letter that does not falsely finalize alendronate as current therapy and that keeps resumption open for nephrology review. B fails that central requirement by turning nonadministration into a continuation plan. A avoids that false continuation and correctly surfaces the inpatient nonadministration. However, the pasted evidence does not show A explicitly asking nephrology to decide whether and when to resume alendronate after renal reassessment. For that reason, A is better, not much better.

Prompt adherence: Both finalize the started referral letter, remove draft scaffolding, preserve the letter format, and produce send-ready DOCX and PDF outputs. Tie on basic prompt adherence.

Correctness: A is better. Both preserve the staged outpatient posture for the held cardiorenal and diabetes agents, avoid a numeric prednisone dose, and use chart-supported renal and infection values. The deciding correctness issue is alendronate. A notes it was not administered inpatient; B falsely says it continues on the Sunday schedule.

Completeness: A covers the major medication course, restart parameters, follow-up coordination, caregiver medication-safety context, and the unresolved antibiotic and home-health caveats. B also covers many of those domains, but its explicit alendronate continuation is worse than A's partial handling of the bone-health item. A may still be incomplete if the final letter does not clearly route the alendronate decision to nephrology.

Methodology: Both read the chart broadly and checked the duplicate draft copies. A makes the safer inference from the MAR by treating alendronate as not administered inpatient. B recognizes the same nonadministration fact but then overrides it with a continuation statement, which is the methodology failure the task is testing.

Quality and clarity: Both are organized and sign-ready. A is clinically cautious and clear about deliberate accuracy choices, including not asserting an antibiotic completion date and not overstating home-health acceptance. B is readable but presents the alendronate error cleanly enough that it would look like an accepted current-medication decision.

Summary: A is preferred with A+ because it catches the key inpatient nonadministration fact and avoids B's unsafe alendronate continuation. The margin is not A++ because A's visible summary does not prove it completed the golden move of leaving alendronate resumption open for nephrology.

## Guardrails (must survive any edit)
1. Preferred output is A.
2. Use A+ rather than A++ unless the downloaded final A letter proves A explicitly keeps alendronate open and routes resumption to nephrology.
3. B appears to be the same 0.400 trajectory used in PL1. Record that if the platform download icons expose bundle IDs.
4. Do not call the duplicate `.apps_data/calendar` draft a content leak in this pair. Both transcripts report identical draft copies.
5. PL 2 of 3 for KM07. One more PL on a distinct pair remains after this one.

## Submit Mechanics
Select A+ (one plus sign), paste the justification from "Preferred output: A" through "Summary" into Comments, submit the preference, confirm it appears in submission history, then run Preference Labels AutoQC.
